About Institute of Fundamental and Clinical Immunology
Clinical Trials at Institute of Fundamental and Clinical Immunology
During the past decade, Institute of Fundamental and Clinical Immunology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on
average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Institute of Fundamental and Clinical Immunology" #1 sponsor was "Russian Academy of Medical Sciences" with 5 trials, followed by "Gilead Sciences" with 2 trials
sponsored, "Amgen" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Seagen Inc."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Institute of Fundamental and Clinical Immunology"
#1 collaborator was "Incyte Corporation" with 1 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Institute of Fundamental and Clinical Immunology
According to Clinical.Site data, the most researched conditions in "Institute of Fundamental and Clinical Immunology" are
"HBV" (2 trials), "Joint Disease" (2 trials), "Arthritis" (1 trials), "Arthritis, Degenerative" (1 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Institute of Fundamental and Clinical Immunology" in a lesser frequency.
Clinical Trials Intervention Types at Institute of Fundamental and Clinical Immunology
Most popular intervention types in "Institute of Fundamental and Clinical Immunology" are "Drug" (7 trials), "Biological" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "TAF" (2 trials), "TAF Placebo" (2 trials), "TDF" (2 trials), "TDF Placebo" (2 trials) and "Apremilast 20mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Institute of Fundamental and Clinical Immunology
The vast majority of trials in "Institute of Fundamental and Clinical Immunology" are
10 trials for "All" genders.
Clinical Trials Status at Institute of Fundamental and Clinical Immunology
Currently, there are NaN active trials in "Institute of Fundamental and Clinical Immunology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Institute of Fundamental and Clinical Immunology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Institute of Fundamental and Clinical Immunology, 5 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Institute of Fundamental and Clinical Immunology
Institute of Fundamental and Clinical Immunology has several departments that took part in Clinical trials: "Laboratory of Clinical Immunopharmacology" - 4 trials